Tag: CureVac

Covid vaccine from Germany’s CureVac just 48% effective: final results

FRANKFURT, Germany (AFP) — Germany’s CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna. The outcome had been expected after poor interim results were released earlier this month. The company in part blamed “the unprecedented context of 15 strains circulating” among the trial volunteers, as well as varying responses across different age groups. The […]

Continue Reading →

Germany’s CureVac Covid vaccine only 47 percent effective: company

BERLIN, Germany (AFP) — A coronavirus vaccine being developed by Germany’s CureVac has shown disappointing results in an interim analysis of its effectiveness, the company said Wednesday. “In the unprecedented context of at least 13 variants circulating within the study population subset assessed at this interim analysis, CVnCoV demonstrated an interim vaccine efficacy of 47 percent against Covid-19 disease of any severity and did not meet prespecified statistical success criteria,” CureVac said in a statement. […]

Continue Reading →